Aeon Secures €8.2 Million to Advance AI Preventive Health Platform

Zurich’s Aeon raises €8.2 million to develop an advanced AI-driven platform focused on early disease detection and personalized health management. Led by Concentric, the funding will aid expansion in Switzerland, Germany, and the UK. With a 0% false positive rate, Aeon stands out in the preventive health market.

Aeon, a HealthTech startup based in Zurich, has just secured a fresh round of funding—€8.2 million, to be exact. This funding, revealed today, comes from a round led by London’s Concentric, alongside contributions from Calm/Storm Ventures, GoHub Ventures, Kadmos Capital, and others, including Swiss super angel investor Daniel Gutenberg. The aim? To elevate its AI-driven platform aimed at early detection and preventive healthcare.

Tim Seithe, the Founder and CEO of Aeon, expressed a bold vision, stating, “We’re redefining preventive care by shifting it from reactive checks to proactive, personalised health management. Our approach goes beyond early disease detection — we’re tackling one of preventive medicine’s biggest challenges: false positives.” He highlighted that every customer of Aeon receives a uniquely tailored risk profile, paired with a robust medical plan designed to monitor and mitigate their health risks over time.

Established in 2023, Aeon is all about preventive health. They offer AI-enhanced check-ups that integrate comprehensive services, including whole-body MRI scans, blood biomarker assays, and genetic analysis. The company’s core mission is to transform healthcare from being reactive to becoming proactive. They want to empower individuals with clarity and confidence regarding their health journey.

The lineup of Aeon includes not just Tim Seithe, but also CPO Samuel Frey, who comes with a wealth of experience, especially from his previous role at Platomics. They’ve also got Dr. Andreas Lemke on board, a renowned MRI physicist and the brains behind Mediaire, a firm focused on AI-driven brain diagnostics. Together, they create a powerful team tackling health challenges head-on.

Now, what makes Aeon unique? Unlike many other health platforms that depend on simpler data like wearables or skin checks, Aeon combines extensive diagnostics through a single check-up, lasting about an hour. They claim to ensure early detection and future prediction of over 500 ailments, all verified by experienced, board-certified physicians.

The numbers don’t lie—so far, they’ve maintained a notable 0% false positive rate during clinical follow-ups. In a field where overdiagnosis often leads to unnecessary treatment, Aeon stands out. They utilize AI for several key functions, including automated imaging analysis to spot irregularities in MRI scans swiftly and accurately, cross-validating various health data to lower false positives, and crafting personalized risk profiles that can indicate the likelihood of various health conditions.

The Global Alliance for Chronic Diseases has drawn attention to concerning statistics—41 million lives are lost annually to non-communicable diseases, many of which are preventable. Aeon asserts that disjointed data and slow-to-evolve healthcare systems hinder prevention efforts. To date, their technology has successfully identified early-stage cancers and conditions such as aneurysms and Alzheimer’s. Notably, one scan even unearthed undiagnosed kidney cancer in a man aged 56, leading to immediate life-saving procedures.

On top of that, Aeon seems to be breaking new ground by being the first platform to offer full-body check-ups that are reimbursable by health insurers. Agreements are in place with Swiss insurance providers, where clients can recover up to 80% of the cost, depending on their plan.

Alex Stroud from Concentric commented enthusiastically, saying, “Aeon is not just another testing solution. Many consumer health products today deliver questionable value. Validated by insurers, Aeon is delivering the most medically robust preventive health product on the market. That rare combination of clinical rigor and commercial scalability is what makes this team so exciting.”

With this new infusion of capital, Aeon is on the path to broaden its reach across Switzerland, Germany, and the UK, with plans for even more international expansions later. They plan to accelerate relationships with insurers and businesses to enhance healthcare access while also boosting their AI platform for earlier, more accurate diagnostics. Moreover, Aeon has its sights set on rolling out over 10 new locations shortly as they build their clinical network further.

Aeon has positioned itself at the forefront of preventive healthcare with a fresh funding boost of €8.2 million. With cutting-edge AI technology and a strategic approach to personal health management, they aim to disrupt traditional healthcare paradigms. The startup’s commitment to early disease detection, validated by insurers, could mean a brighter, healthier future for many. As they grow, their focus on scaling operations and enhancing diagnostic precision will likely play a crucial role in addressing the impending challenges of chronic diseases.

Original Source: www.eu-startups.com